Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: Implications for calcium oxalate stone genesis

Chemistry and Biology

Volumn 10, Issue 3, 2003, Pages 271-278

  Grover, Phulwinder K ^a   Marshall, Villis R ^a,b   Ryall, Rosemary L ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037350328     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(03)00057-7     Document Type: Article

References (43)

1. Yu T.-F., Gutman A.B. Uric acid nephrolithiasis in gout. Ann. Intern. Med. 67:1967;1133-1148.
2. Smith M.J.V., Hunt L.D., King J.S. Jr., Boyce W.H. Uricaemia and urolithiasis. J. Urol. 101:1969;637-642.
3. Dent C.E., Sutor D.J. Presence or absence of an inhibitor of calcium oxalate crystal growth in urine of normals and stone-formers. Lancet. 2:1971;775-778.
4. Coe F.L., Raisen L. Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1:1973;129-131.
5. Coe F.L., Kavalach A.G. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N. Engl. J. Med. 291:1974;1344-1350.
6. Smith M.J.V., Boyce W.H. Allopurinol and urolithiasis. J. Urol. 102:1969;750-753.
7. Pak C.Y.C., Barilla D.E., Holt K., Brinkey L., Tolentino R., Zerwekh J.E. Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis. Am. J. Med. 65:1978;593-599.
8. Miano L., Petta S., Gallucci M. Allopurinol in the prevention of calcium oxalate renal stones. Eur. Urol. 5:1979;229-232.
9. Maschio G., Tessitore N., D'Angelo A., Fabris A., Pagano F., Tasca A., Graziani G., Aroldi A., Surian M., Colussi G.et al. Prevention of calcium nephrolithiasis with low dose thiazide, amiloride and allopurinol. Am. J. Med. 71:1981;623-626.
10. Smith M.J.V. Placebo versus allopurinol for recurrent urinary calculi. Proc. Eur. Dial. Transplant Assoc. 20:1983;422-426.
11. Ettinger B., Tang A., Citron J.T., Livermore B., Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N. Engl. J. Med. 315:1986;1386-1389.
12. Coe F.L., Lawton R.N., Goldstein R.B., Tembe V. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc. Soc. Exp. Biol. Med. 149:1975;926-929.
13. Pak C.Y.C., Arnold L.H. Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc. Soc. Exp. Biol. Med. 149:1975;930-932.
14. Robertson W.G., Knowles F., Peacock M. Urinary mucopolysaccharide inhibitors of calcium oxalate crystallization. Fleisch H., Robertson W.G., Smith L.H., Vahlensieck W. Urolithiasis Research. 1976;Plenum Press, New York and London. 331-334.pp.
15. Kallistratos G., Timmermann A., Fenner O. Zum Einfluss des Aussalzeffektes auf die Bildung von calciumoxalat-Kristallen im menschlichen Harn. Naturwissenschaften. 57:1970;198.
16. Desnoyers J.E., Jolicoeur C. Hydration effects and thermodynamic properties of ions. Mod. Aspects Electrochem. 5:1969;1-89.
17. Atkins P.W. Physical Chemistry. 1995;Oxford University Press, Oxford.
18. Chang R. Physical Chemistry with Applications to Biological Systems. 1977;Macmillan Publishing, New York.
19. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
20. Roman J., Andres P., Alvarez M.A., Torres A. Salting out procedure for isolation of DNA from stored bone marrow slides for PCR. Eur. J. Haematol. 50:1993;237-238.
21. Hegardt F.G., Pie A. Sodium citrate salting out of the human blood serum proteins. Rev. Esp. Fisiol. 24:1968;161-168.
22. Foster P.R., Dunnill P., Lilly M.D. Salting out of enzymes with ammonium sulphate. Biotechnol. Bioeng. 13:1971;713-718.
23. Smith S.W. A new salting out technique for colorimetric free fatty acid assays. Anal. Biochem. 67:1975;531-539.
24. Mayer G.G., Chase T., Farvar B., Al Waidh M., Longo F., Karp F., Zinsser H.H. Metabolic studies on the formation of calcium oxalate stones, with special emphasis on vitamin B6 and uric acid metabolism. Bull. N. Y. Acad. Med. 44:1968;28-44.
25. Grover P.K., Ryall R.L., Marshall V.R. Effect of urate on calcium oxalate crystallization in human urine. evidence for a promotory role of hyperuricosuria in urolithiasis Clin. Sci. 79:1990;9-15.
26. Grover P.K., Ryall R.L., Marshall V.R. Calcium oxalate crystallization in urine. role of urate and glycosaminoglycans Kidney Int. 41:1992;149-154.
27. Grover P.K., Ryall R.L., Marshall V.R. Dissolved urate promotes calcium oxalate crystallization. epitaxy is not the cause Clin. Sci. 85:1993;303-307.
28. Ryall R.L., Hibberd C.M., Marshall V.R. A method for studying inhibitory activity in whole urine. Urol. Res. 13:1985;285-289.
29. Ryall R.L. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J. Urol. 15:1997;155-164.
30. Finlayson B. Calcium stones. some physical and chemical aspects David D.S. Calcium Metabolism in Renal Failure and Nephrolithiasis. 1977;John Wiley and Sons, New York. 337-382.pp.
31. Ryall R.L., Grover P.K., Marshall V.R. Urate and calcium stones. picking up a drop of mercury with one's fingers? Am. J. Kidney Dis. 17:1991;426-430.
32. Grover P.K., Ryall R.L. Urate and calcium oxalate stones. from repute to rhetoric to reality Miner. Electrolyte Metab. 20:1994;361-370.
33. Grover P.K., Ryall R.L. Urate and calcium oxalate stones. A new look at an old controversy Khan S.R. Calcium Oxalate in Biological Systems. 1995;CRC Press, New York. 305-321.pp.
34. Hallson P.C., Rose G.A., Sulaiman S. Urate does not influence the formation of calcium oxalate crystals in whole human urine at pH 5.3. Clin. Sci. 62:1982;421-425.
35. Ryall R.L., Grover P.K., Harnett R.M., Hibberd C.M., Marshall V.R. Small-molecular-weight inhibitors. Walker V.R., Sutton R.A.L., Cameron E.C.B., Robertson W.G. Urolithiasis. 1989;Plenum Press, New York. 91-96.pp.
36. Doyle I.R., Ryall R.L., Marshall V.R. The effect of low speed centrifugation and millipore filtration on the urinary protein content. Walker V.R., Sutton R.A.L., Cameron E.C.B., Pak C.Y.C., Robertson W.G. Urolithiasis. 1989;Plenum Press, New York. 593-594.pp.
37. Ryall R.L., Harnett R.M., Hibberd C.M., Edyvane K.A., Marshall V.R. Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine. Urol. Res. 19:1991;181-188.
38. Quilan K.P., DeSesa M.A. Spectrophotometric determination of phosphorus as molybdovanadosphosphoric acid. Anal. Chem. 27:1955;1626-1629.
39. Mazzachi B.C., Teubner J.L., Ryall R.L. Factors affecting measurement of urinary oxalate. Clin. Chem. 30:1984;1339-1343.
40. Lundquist P., Martenssen J., Sorbo B., Ohman S. Turbidity of inorganic sulphate, ester sulphate, and total sulphur in urine. Clin. Chem. 26:1980;1178-1181.
41. Mroz E.A., Roma R.J., Lechene C. Fluorescence assay for picomole quantities of ammonia. Kidney Int. 21:1982;524-527.
42. Sutor D.J., Wilkie L.I. The estimation of pyrophosphate in urine with uridine-5-diphosphoglucose pyrophosphorylase. Clin. Chim. Acta. 86:1978;329-332.
43. Tompkins D., Toffaletti J. Enzymatic determination of citrate in serum and urine, with the use of Worthington "Ultrafree" device. Clin. Chem. 28:1982;192-195.